智能工厂

With the establishment of the facility management system, the company is now able to reduce inventory and purchase cost by optimizing the life cycle of facility and component replacement, improving facility performance, securing visibility of facility components and improving efficiency in component supply.

The company has applied process realignment and a new system throughout the entire manufacturing for 30 factory lines nationwide.
As a result, the company has become able to improve work efficiency, prevent user error and find out/track manufacturing process information.

The company has established a quality analysis platform for the entire company through Brightics AI by securing data regarding quality of process of components, manufacturing, sipping and arrival to the market in order to establish a smart quality management system.

Partners have secured the ground for energy reduction through energy visualization at workplaces, which enables them to have responsible operation of the facilities and systems.

The global standard EHS platform has been established based on new technologies as well as standardization of EHS system work process, which enables the company to respond to Korean and overseas laws and regulations and prevent environment & safety accidents.

We built the global sales and production plan management system over different product groups, including mobile and home appliances of manufacture and sales subsidiaries all over six continents. Since all employees all around the globe share the same information anywhere, any time, it is possible to have quick and transparent decision-making. Also, SCM operation efficiency has escalated by increasing the forecast accuracy using the new technology, including distribution data analysis and AI-based sales forecast, and preventing out-of-stock.

Pharmaceuticals needs to establish a manufacturing plan reflecting regulations for each country and customer. Also, it needs demand management considering the transparency of the distribution route and diversity of the distribution channel. Through SCM solution from Samsung SDS, establish the “Demand-Supply Consensus-based Plan System” which reflects the characteristics of pharmaceuticals and leads to the decrease of inventory cost and increase of operational efficiency.

There is an increasing demand for integrated and flexible management of the Manufacturing Execution System (MES) for global expansion. To accommodate these customer needs, Samsung SDS transitioned the MES to the public cloud for the reliability, processing speed and performance at a similar level as on-premise environments.

By applying Brity RPA solution to all processes, including manufacturing, development, sales, and quality assurance, the efficiency of repetitive tasks and routine monitoring and reporting processes can be greatly enhanced.

The Manufacturing Execution System (MES) needed to expand in global production more flexibly and actively. Samsung SDS applied cloud-based architecture and platform(PaaS)-based standard development/operation environments to reduce IT cost and reinforce manufacturing stability.